Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer Immunotherapy

HN Chang, BY Liu, YK Qi, Y Zhou… - Angewandte Chemie …, 2015 - Wiley Online Library
Blockade of the protein–protein interaction between the transmembrane protein
programmed cell death protein 1 (PD‐1) and its ligand PD‐L1 has emerged as a promising …

Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy.

HN Chang, BY Liu, YK Qi, Y Zhou, YP Chen… - … (International ed. in …, 2015 - europepmc.org
Blockade of the protein-protein interaction between the transmembrane protein programmed
cell death protein 1 (PD-1) and its ligand PD-L1 has emerged as a promising …

Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy.

HN Chang, BY Liu, YK Qi, Y Zhou… - Angewandte …, 2015 - search.ebscohost.com
Blockade of the protein-protein interaction between the transmembrane protein programmed
cell death protein 1 (PD-1) and its ligand PD-L1 has emerged as a promising …

Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer Immunotherapy

HN Chang, BY Liu, YK Qi, Y Zhou, YP Chen… - Angewandte Chemie …, 2015 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Blockade of the protein–protein interaction
between the transmembrane protein programmed cell death protein 1 (PD‐1) and its ligand …

Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer Immunotherapy

HN Chang, BY Liu, YK Qi, Y Zhou, YP Chen… - Angewandte …, 2015 - Wiley Online Library
Blockade of the protein–protein interaction between the transmembrane protein
programmed cell death protein 1 (PD‐1) and its ligand PD‐L1 has emerged as a promising …

Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer Immunotherapy

HN Chang, BY Liu, YK Qi, Y Zhou, YP Chen… - Angewandte …, 2015 - infona.pl
Blockade of the protein–protein interaction between the transmembrane protein
programmed cell death protein 1 (PD‐1) and its ligand PD‐L1 has emerged as a promising …

[引用][C] Blocking of the PD-1/PD-L1 Interaction by aD-Peptide Antagonist for Cancer Immunotherapy

HN Chang, BY Liu, YK Qi, Y Zhou… - Angewandte …, 2015 - ui.adsabs.harvard.edu
Blocking of the PD-1/PD-L1 Interaction by aD-Peptide Antagonist for Cancer Immunotherapy -
NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS Blocking of the …

Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy

HN Chang, BY Liu, YK Qi, Y Zhou… - … (International ed. in …, 2015 - pubmed.ncbi.nlm.nih.gov
Blockade of the protein-protein interaction between the transmembrane protein programmed
cell death protein 1 (PD-1) and its ligand PD-L1 has emerged as a promising …

Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy.

HN Chang, BY Liu, YK Qi, Y Zhou… - Angewandte …, 2015 - search.ebscohost.com
Blockade of the protein-protein interaction between the transmembrane protein programmed
cell death protein 1 (PD-1) and its ligand PD-L1 has emerged as a promising …

Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer Immunotherapy

HN Chang, BY Liu, YK Qi, Y Zhou, YP Chen… - Angewandte Chemie …, 2015 - infona.pl
Blockade of the protein–protein interaction between the transmembrane protein
programmed cell death protein 1 (PD‐1) and its ligand PD‐L1 has emerged as a promising …